Dr. Krista Lanctôt presents findings from the ADMET 2 Trial, exploring variability in methylphenidate response for apathy in Alzheimer’s disease and its implications for managing neuropsychiatric symptoms.
Moderator: Daniella Vellone
Speaker: Krista Lanctôt
Moderator: Daniella Vellone
Speaker: Krista Lanctôt
Date & Time
Wednesday February 5th, 2025 10:00am CST
End Date & Time
Wednesday February 5th, 2025 11:00am CST
Category ISTAART Webinars
.png)